New York, NYNCT04190862Now EnrollingIRB Ready

Anal Fistula Clinical Trial in New York, NY

Access cutting-edge anal fistula treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Weill Medical College of Cornell University

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access anal fistula specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related anal fistula treatment provided free

Apply for This New York Location

Check if you qualify for this anal fistula clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Anal Fistula Study in New York

The purpose of this study is to determine if endothelial cells derived from human umbilical vein are safe for use in conjunction with fistulotomy for the treatment of simple anal fistulas. Endothelial cells are a special kind of cell in the body that line the inside surface of blood vessels. The goal of the study is to evaluate the preliminary safety of human umbilical vein cells in anal fistula healing.

Sponsor: Weill Medical College of Cornell University

Who Can Participate

Inclusion Criteria

Subject ages 18 or older
Subject willing and able to provide informed consent
Subject is medically eligible and have agreed to undergo a fistulotomy
Subject with simple perianal fistula with 2 or fewer fistula tracts
Maximum tract length of 3 inches
Subject without history of Crohn's disease/ Ulcerative Colitis
For female subjects of childbearing potential:
A negative serum or urine pregnancy test at screening is required prior to enrollment
Subject must be willing to use a highly effective method of contraception from the start of the screening period throughout the study period
For males who can father a child and are having intercourse with females of childbearing potential who are not using adequate contraception:
Subject must be willing to use a recommended method of contraception and refrain from sperm donation from the start of the conditioning therapy for at least 1 year after completion and discussion with a treating physician

Exclusion Criteria

Concomitant rectovaginal fistulas
Subjects with an abscess
Presence of active infections findings (e.g.; redness, swelling, tenderness or fever)
Presence of rectal and/or anal stenosis
The presence of setons unless removed prior to the treatment
Subjects with ongoing steroid treatment or treated with steroids in the last 4 weeks
Renal impairment defined by creatinine clearance below 90 mL/min calculated using Cockcroft-Gault formula or by serum creatinine ≥ 1.5 x upper limit of normality (ULN)
Hepatic impairment defined by both of the following laboratory ranges:
Total bilirubin ≥ 1.5 x ULN unless benign congenital hyperbilirubinemia
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≥ 2.5 x ULN
Known history of abuse of alcohol or other addictive substances in the 6 months prior to enrollment
Active malignant tumor within 5 years
Current recent history of abnormal, severe, progressive, uncontrolled hepatic, hematological, gastrointestinal, endocrine, pulmonary, cardiac, neurological, psychiatric, or cerebral diseases
Congenital or acquired immunodeficiencies including human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS)
Major surgery or severe trauma within the previous 6 months
Subjects who are candidates for solid organ transplantation or who may have a high likelihood of needing a solid organ transplant (ex. progressive heart failure)
Females who are who are pregnant or breastfeeding or planning to become pregnant or breastfeed during treatment
Subjects who have known hypersensitivity or documented allergy to DMSO
Subjects who do not wish to or cannot comply with study procedures
Subjects currently receiving, or having received any investigational drug within 3 months prior to E-CEL UVEC cell therapy

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT04190862) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Anal Fistula Treatment Options in New York, NY

If you're searching for anal fistula treatment options in New York, NY, this clinical trial (NCT04190862) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced anal fistula specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY